Impact of augmenting dialysis frequency and duration on cardiovascular function

ASAIO Journal

Volumn 52, Issue 6, 2006, Pages

  Ly, Joseph ^a   Chan, Christopher T ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; CELLS; DISEASES; PATIENT TREATMENT; PHYSIOLOGY; RISK MANAGEMENT;

CARDIOVASCULAR MORBIDITY; CONVENTIONAL HEMODIALYSIS (CHD); ENDOTHELIAL REPAIR;

DIALYSIS;

ADAPTATION; ANEMIA; ARTERY DISEASE; CARDIOVASCULAR DISEASE; CELL REGENERATION; CONFERENCE PAPER; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE INJURY; HEART RATE VARIABILITY; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; NIGHT; NOCTURNAL HEMODIALYSIS; PATHOGENESIS; PRESSORECEPTOR REFLEX; RISK FACTOR; SLEEP APNEA SYNDROME; SODIUM RETENTION; STEM CELL; VASODILATATION; WATER RETENTION;

APPOINTMENTS AND SCHEDULES; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIUM;

EID: 33751234800     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000249504.07371.5e     Document Type: Conference Paper

References (28)

1. Parfrey PS, Foley RN, Harnett JD, et al: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996.
2. Foley RN, Parfrey PS, Morgan J, et al: Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58: 1325-1335, 2000.
3. London GM: Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 16: 85-94, 2003.
4. Foley RN, Parfrey PS, Kent GM, et al: Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11: 912-916, 2000.
5. London GM, Guerin AP, Marchais SJ, et al: Cardiac and arterial interactions in endstage renal disease. Kidney Int 50: 600-608, 1996.
6. Lins RL, Elseviers M, Rogiers P, et al: Importance of volume factors in dialysis related hypertension. Clin Nephrol 48: 29-33, 1997.
7. Chaignon M, Chen WT, Tarazi RC, et al: Effect of hemodialysis on blood volume distribution and cardiac output. Hypertension 3: 327-332, 1981.
8. Zoccali C, Mallamaci F, Benedetto FA, et al: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12: 1508-1515, 2001.
9. Chazot C, Charra B, Laurent G, et al: Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 10: 831-837, 1995 .
10. Leenen FH, Smith DL, Khanna R, et al: Changes in left ventricular hypertrophy and function in hypertensive patients started on continuous ambulatory peritoneal dialysis. Am Heart J 110: 102-106, 1985.
11. Onesti G, Kim KE, Greco JA, et al: Blood pressure regulation in end-stage renal disease and anephric man. Circ Res 36: 145-152, 1975.
12. London G, Guerin A, Pannier B, et al: Increased systolic pressure in chronic uremia: role of arterial wave reflections. Hypertension 20: 10-19, 1992.
13. London GM, Pannier B, Guerin AP, et al: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12: 2759-2767, 2001.
14. Klassen PS, Lowrie EG, Reddan DN, et al: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287: 1548-1555, 2002.
15. Blacher J, Guerin AP, Pannier B, et al: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434-2439, 1999.
16. Blacher J, Guerin AP, Pannier B, et al: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001.
17. Blacher J, Demuth K, Guerin AP, et al: Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18: 535-541, 1998.
18. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
19. Pannier B, Guerin AP, Marchais SJ, et al: Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 57: 1091-1099, 2000.
20. Joannides R, Bakkali EH, Le Roy F, et al: Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 12: 2623-2628, 1997.
21. Szmitko PE, Fedak PW, Weisel RD, et al: Endothelial progenitor cells: new hope for a broken heart. Circulation 107: 3093-3100, 2003.
22. Uldall R, Ouwendyk M, Francoeur R, et al: Slow nocturnal home hemodialysis at the Wellesley Hospital. Adv Ren Replace Ther 3: 133-136, 1996.
23. Chan CT: Cardiovascular effects of frequent intensive hemodialysis. Semin Dial 17: 99-103, 2004.
24. Chan CT, Floras JS, Miller JA, et al: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002.
25. Chan CT, Harvey PJ, Picton P, et al: Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 42: 925-931, 2003.
26. Chan CT, Mardirossian S, Faratro R, et al: Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis. Am J Kidney Dis 41: 225-229, 2003.
27. Chan CT, Jain V, Picton P, et al: Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 68: 338-344, 2005.
28. Chan CT, Li SH, Verma S: Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 289: F679-F684, 2005.